Open the News about your Business

U.S. Stock: United Therapeutics Corp

Sep 25, 2024Finance0

Company: United Therapeutics CorporationBloomberg ticker: UTHR USMarket cap: US$12,777mBackground: United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company’s lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously.

World Class Benchmarking of United Therapeutics Corp
 

  • Profitable Growth rank of 1 was up compared to the prior period’s 2nd rank
  • This is World Class performance compared to 380 large Health Care companies worldwide
  • Profitability rank of 1 was better than its Growth rank of 3
  • Profitability rank of 1 was the same compared to the prior period’s 1st rank
  • This is World Class performance compared to peers
  • Growth rank of 3 was up compared to the prior period’s 4th rank
  • This is above average performance compared to peers

    • More By This Author:Asian Stock: Bumi Armada
    Asian Stock: GFPT
    Asian Stock: Genting Berhad

    Reviews

    • Total Score 0%
    User rating: 0.00% ( 0
    votes )
    PayPal enables business accounts to buy, hold, and sell crypto

    Related articles

    Leave a Reply

    Your email address will not be published. Required fields are marked *